Search for: "Mallinckrodt PLC" Results 1 - 2 of 2
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Dec 2017, 11:35 am by Nate Nead
Paganini will complement OncoResponse, since OncoResponse has a strong focus on antibody cancer drugs and Paganini recently developed ONCR-201, a monoclonal antibody used in treating ovarian cancer.[29] Mallinckrodt PLC is expected to purchase Ocera Therapeutics Inc. in addition to its mid-stage hepatic encephalopathy, for about $42 million and to close in the fourth quarter of 2017. [read post]
20 Oct 2018, 1:00 pm by Corbin Bridge
Baxter International Inc. acquired two hemostat and sealant products from Mallinckrodt plc. for $153 million. [read post]